Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anu Usvasalo"'
Autor:
Anu Usvasalo, Riikka Räty, Sakari Knuutila, Kim Vettenranta, Arja Harila-Saari, Esa Jantunen, Marjut Kauppila, Pirjo Koistinen, Katriina Parto, Pekka Riikonen, Toivo T. Salmi, Raija Silvennoinen, Erkki Elonen, Ulla M. Saarinen-Pihkala
Publikováno v:
Haematologica, Vol 93, Iss 8 (2008)
Background Interest has recently been paid to adolescents and young adults with acute lymphoblastic leukemia, particularly because all reports so far published indicate that these patients have a better outcome when treated with pediatric rather than
Externí odkaz:
https://doaj.org/article/68767df05d8543a6af6d5a5c6c3b3c96
Autor:
Anu Usvasalo, Marja-Liisa Karjalainen-Lindsberg, Virinder Kaur Sarhadi, Neda Mosakhani, Sakari Knuutila, Leo Lahti, Ulla M. Saarinen-Pihkala, Katja Tuononen
Publikováno v:
Leukemia & Lymphoma. 53:2517-2520
Childhood acute lymphoblastic leukemia (ALL) is a genetically and prognostically heterogeneous malignancy with a mortality rate of 20% [1]. The identification of novel prognostic biomarkers is, the...
Autor:
Pirjo Koistinen, Anu Usvasalo, Sakari Knuutila, Kim Vettenranta, Riikka Räty, Eeva-Riitta Savolainen, Arja Harila-Saari, Erkki Elonen, Suvi Savola, Ulla M. Saarinen-Pihkala
Publikováno v:
Leukemia Research. 32:1228-1235
Deletion in chromosome 9p involving the CDKN2A locus (9p21.3) is known in many malignancies. To detect this deletion in adolescent ALL patients we used oligo array CGH and studied 54 patients aged 10–25 years. Deletion rate was 25/54 (46%), of thes
Autor:
Katriina Parto, Marjut Kauppila, Toivo T. Salmi, Pirjo Koistinen, Erkki Elonen, Anu Usvasalo, Esa Jantunen, Riikka Räty, Arja Harila-Saari, Raija Silvennoinen, Ulla M. Saarinen-Pihkala, Sakari Knuutila, Pekka Riikonen, Kim Vettenranta
Publikováno v:
Haematologica. 93:1161-1168
Background Interest has recently been paid to adolescents and young adults with acute lymphoblastic leukemia, particularly because all reports so far published indicate that these patients have a better outcome when treated with pediatric rather than
Autor:
Sakari Knuutila, Jaakko Hollmén, Erkki Elonen, Anu Usvasalo, Eeva-Riitta Savolainen, Riikka Räty, Pirjo Koistinen, Arja Harila-Saari, Ulla M. Saarinen-Pihkala
Publikováno v:
Leukemia research. 34(11)
The development of risk-adapted therapy has improved the treatment results of acute lymphoblastic leukemia (ALL) especially in children. However, more accurate risk classifiers are warranted. In this study we aimed at defining a prognostic classifier
Autor:
Riikka Räty, Ulla M. Saarinen-Pihkala, Anu Usvasalo, Sakari Knuutila, Jaakko Hollmén, Shinsuke Ninomiya, Erkki Elonen
Publikováno v:
Genes, Chromosomes and Cancer.
Copy number losses in chromosome arm 9p are well-known aberrations in malignancies, including leukemias. The CDKN2A gene is suggested to play a key role in these aberrations. In this study overviewing 9p losses in hematologic neoplasias, we introduce
Autor:
Erkki Elonen, Anu Usvasalo, Kim Vettenranta, Eeva-Riitta Savolainen, Sakari Knuutila, Riikka Räty, Pirjo Koistinen, Arja Harila-Saari, Ulla M. Saarinen-Pihkala
Publikováno v:
Cancer genetics and cytogenetics. 192(1)
Current cytogenetic techniques have enabled more accurate definition of genetic aberrations in the lymphoblasts of patients with acute lymphoblastic leukemia (ALL), at least in most cases. Detecting the cryptic aberrations undetected by conventional
Autor:
Arja Harila-Saari, Kim Vettenranta, Pirjo Koistinen, Riikka Räty, Anu Usvasalo, Ulla M. Saarinen-Pihkala, Erkki Elonen, Eeva-Riitta Savolainen, Sakari Knuutila
Publikováno v:
Blood. 112:1491-1491
Development of cytogenetic methods has contributed to the understanding that ALL is not a homogenous disease. Detection of structural and numerical alterations in the chromosomes of lymphoblasts has identified several different ALL subgroups. G-bandi
Publikováno v:
Blood. 108:1885-1885
Background: Long-term survival in pediatric acute lymphoblastic leukemia has dramatically improved during the past three decades through intensification of therapy. Progress has also been made regarding therapy of adult ALL. Recent reports in the lit